In vitro and in vivo models in reproductive toxicology Nicole Clemann, PhD F. Hoffmann-La Roche AG, Basel Master Course in Toxicology Section: Reproductive Toxicology May 10, 2016 Swiss Center of Applied Human Toxicology What do we do and when? Drug discovery and development process – In silico tools – In vitro systems – In vivo systems • Embryo-fetal development • Fertility studies • Pre- and postnatatal studies 2 $ Costs: $ 1000 Mio. $ $ In vitro $ $ $ $ $ Market Registration Phase III Phase II Phase I Phase 0 Lead Optimization and Clinical Candidate Selection (CCS) Lead Identification Target Assessment Proposal Process Drug Discovery and Development Process What are we doing and when? ~ 14.2 years In silico In vivo 3 Reproductive Cycle Growth & development Post-natal adaptation Parturition Fetal growth Sexual maturation Gamete production Release of gametes Interaction of gametes Transport of zygote ♀ Organogenesis Implantation 4 5 In silico tools e.g. DEREK, CASE/MCASE (Multi Computer Automated Structure Evaluation), VITEC: -Knowledge-based computer system (program) designed for organizing biological/toxicological data obtained from evaluation of diverse chemicals. These programs: - can automatically identify biological hazards based on substructures molecular - based on learning set positive and negative compounds - MCASE use the concept of biophores and modulators. * Windows based Structure-Activity Relationship (SAR) automated expert system 6 What do we do and when? Drug discovery and development process – In silico tools – In vitro systems – In vivo systems • Embryo-fetal development • Fertility studies • Pre- and postnatatal studies 7 In vitro test systems in reproductive toxicology • Female fertility – Ovary cell cultures (e.g. granulosa, thecal, stromal cell cultures) • Male fertility – Testicular cell cultures (e.g. Sertoli cells, germ cells, Leydig cell) • Embryo-fetal development – Whole embryo cultures (rats, chick, frog……) – Primary cell cultures or organ cultures (limb bud……) – Cell lines (embryonic stem cells) – Zebrafish (Danio rerio) • Pre- and postnatal toxicity: ??? 8 Rat Whole Embryo Culture Principle: 9.5 days embryo (serum), incubate for 48 h Endpoints: Growth, differentiation, dysmorphogenesis, vascularization of yolksac, Haematopoesis, DNA-content… 9 Embryonic Stem Cell Culture Principle: Omnipotent (mouse) stem cells differentiate into cardiomyocytes Endpoints: Cytotoxicity, inhibition of differentiation, gene expression http://www.csa.com/discoveryguides/stemcell/images/pluri.jpg 10 Zebrafish assay 1 cell 5 hpf 18 hpf Day 1 Blastula Before hatching After hatching body plan, brain, sense organs, beating heart Day 2-4 Most organs developed (e.g. gut, liver, jaw) Day 5 End of embryogenesis Free swimming larva Principle • Development of a zebrafish embryo in 5 days (from egg to larvae) Endpoints • Growth, differentiation, dysmorphogenesis Chapin, 2008 11 Limitations of alternative tests • Closed system – No maternal metabolic activation • Preincubation with S9 is possible • No maternal influence – Kinetics – Physiology • E.g. nifedine – hypotensive action • Limited tissue types and/or duration of development • Feasibility of tests often limited by solubility or cytotoxicity – May give equivocal results Useful as early screening tools and eg mechanistic tools 12 Guidelines ICH M3(R2): “Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals” (Feb 2012, Step 5) Purpose: “...to recommend international standards for, and promote harmonisation of, the nonclinical safety studies recommended to support human clinical trials of a given scope and duration and marketing authorization…” ICH S5(R2): “Detection of Toxicity to Reproduction for Medicinal Products & (November 2005) Toxicity to Male Fertility” Purpose: “… to reveal any effect of one or more active substances on mammalian reproduction 14 What do we do and when? Drug discovery and development process – In silico tools – In vitro systems – In vivo systems • Embryo-fetal development • Fertility studies • Pre- and postnatatal studies 15 Test for embryo-fetal development (teratology) (rat & rabbit) Mating Gametogenesis Birth Gestation Organogenesis Implantation Start with mated animals treatment Weaning Lactation A u t o p s y Gametogenesis F1 Puberty Parameter • • • • • • • • General toxicity dam (body weight, food consumption…..) Exposure dam (kinetic) Exposure fetus Number and quality of implantations Intrauterine mortality (embryo or fetus) Fetal weight, sex Anomalies external, visceral, skeletal Histopathology 16 Evaluation of Rat Fetuses (day 21) external skeletal visceral (N=800; 4 g; 3.5cm) N=400 N=400 17 What do we do and when? Drug discovery and development process – In silico tools – In vitro systems – In vivo systems • Embryo-fetal development • Fertility studies • Pre- and postnatatal studies 18 Study for Fertility and Early Embryonic Development Mating Gametogenesis Birth Gestation male 2-9 weeks female 2 weeks implantation Gametogenesis F1 Weaning Lactation A u t o p s y (rat/mouse) Puberty Parameter • Parental toxicity (body weight, food consumption, clinical signs) • Estrus cycle • time to mating • mating success • number and quality of implantations • sperm parameters (CASA) • histopathology (testes/ovaries) Start with mated animals treatment Rats are hyperfertile ! 19 Sperm evaluation Motility Count number of sperm: Ultrasonic resistant sperm heads from homogenized testis tissue Sperm from epididymis dilution slide Microscope CASA (Computer Assisted Semen Analyzer) motility, velocity, direction… • motile and / immotile • morphology 20 What do we do and when? Drug discovery and development process – In silico tools – In vitro systems – In vivo systems • Embryo-fetal development • Fertility studies • Pre- and postnatatal studies 21 Pre- and postnatal development Influence during intrauterine development and lactation may have impact on: • Change from intrauterine to extrauterine life (birth) • Metabolism, endocrine function….. • Neurologic function (e.g. reflexes) • Intellectual ability (learning ability, behavior) • Ability to reproduction 22 Study for pre- and postnatal development (rats/mice) Birth Mating Gametogenesis Gestation Weaning Lactation Puberty Gametogenesis (mating F1) Parameter Implantation Treatment Start with mated animals Rearing behavior Pup mortality Body Weight Reflexes Developmental landmarks Sex ratio Behavior Motor activity Sexual development A u t o p s y Fertility of F1 generation 23 Summary / General Consideration • Assess potential hazard and risk of a drug for humans on reproduction • In-silico tools and in vitro tests allow a first hazard assessment (screening) • Approach in animals studies is to assess: – Fertility and early embryonic development until implantation – Embryo-fetal development – Pre- and Postnatal Development • Species are: Rat < Rabbit < Mouse < Cynomolgus monkey • Timing and Design of studies are regulated by internationally harmonized Guidelines (ICH) • Timing and Design of studies also depend on indication and target • Studies have to comply with Good Laboratory Practice (GLP) • Conduct of studies requires a high degree of spezialisation and experience 24 Acknowledgements Acknowledgment Heinrich Bürgin Samia Khalil Georg Schmitt Paul Barrow Alessandro Brigo Claudia McGinnis 25 Questions? 26 References • Chapin R. et al (2008). State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Def. Res. 83 (4), 446-456 • Flint O.P. (1984). An in vitro assay for teratogens with cultures of rat embryo midbrain and limb cells. Tox Appl. Pharm. 76, 383-395 • New D.A.T. (1978). Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. 53, 81-122 27 Doing now what patients need next